Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis
- PMID: 36314483
- PMCID: PMC9735371
- DOI: 10.1002/acn3.51690
Brain magnetic resonance imaging predictors in anti-N-methyl-D-aspartate receptor encephalitis
Abstract
Objective: Brain magnetic resonance imaging (MRI) findings in anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis are nonspecific and rarely have obvious associations with clinical characteristics and outcomes. This study aimed to comprehensively describe the MRI features of patients with NMDAR encephalitis, examine their associations with clinical characteristics, and evaluate their predictive power for disease recurrence and prognosis.
Methods: We retrospectively extracted the clinical data and brain MRI findings of 144 patients with NMDAR encephalitis. Patients underwent a 2-year follow-up to assess disease outcomes. We evaluated the associations of brain MRI findings at the onset with clinical characteristics, recurrence, and prognosis.
Results: Initial MRI showed typical abnormalities in 65 patients (45.1%); of these, 34 (29.3%) developed recurrence and 10 (9.4%) had poor prognosis (mRS ≥3). Binary logistic regression analyses revealed that insula abnormalities were associated with acute seizure (odds ratio [OR] = 3.048, 95% confidence interval [CI]: 1.026-9.060) and white matter lesions were associated with cognitive impairment (OR = 2.730, 95% CI: 1.096-6.799). Risk factors for a poor 2-year prognosis included a higher number of brain MRI abnormalities (OR = 1.573, 95% CI: 1.129-2.192) and intensive care unit (ICU) admissions (OR = 15.312, 95% CI: 1.684-139.198). The risk factors for 2-year recurrence included abnormalities of the thalamus (HR = 3.780, 95% CI: 1.642-8.699).
Interpretations: Brain MRI features of patients with NMDAR encephalitis were associated with clinical manifestations, prognosis, and recurrence. Higher numbers of MRI abnormalities and ICU admissions were predictive of poor prognosis. Abnormalities of the thalamus constituted a recurrence-related risk factor.
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Conflict of interest statement
The authors declare that there are no conflicts of interest in connection with this article.
Figures


Similar articles
-
Brain magnetic resonance imaging as predictors in pediatric anti-N-methyl-D-aspartate receptor encephalitis.Mult Scler Relat Disord. 2024 Feb;82:105061. doi: 10.1016/j.msard.2023.105061. Epub 2023 Dec 21. Mult Scler Relat Disord. 2024. PMID: 38134605
-
Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study.Mult Scler Relat Disord. 2024 Jan;81:105133. doi: 10.1016/j.msard.2023.105133. Epub 2023 Nov 13. Mult Scler Relat Disord. 2024. PMID: 37984120
-
Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study.Mult Scler Relat Disord. 2023 Dec;80:105063. doi: 10.1016/j.msard.2023.105063. Epub 2023 Oct 18. Mult Scler Relat Disord. 2023. PMID: 37913674
-
Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis.Biomed Res Int. 2020 Apr 14;2020:7506590. doi: 10.1155/2020/7506590. eCollection 2020. Biomed Res Int. 2020. PMID: 32352007 Free PMC article. Review.
-
Magnetic resonance imaging and magnetic resonance spectroscopy in a young male patient with anti-N-methyl-D-aspartate receptor encephalitis and uncommon cerebellar involvement: A case report with review of the literature.Neuroradiol J. 2016 Feb;29(1):30-5. doi: 10.1177/1971400915609333. Epub 2015 Nov 27. Neuroradiol J. 2016. PMID: 26613928 Free PMC article. Review.
Cited by
-
Identifying Key Prognostic Indicators for Relapse and Chronic Epilepsy in Autoimmune Encephalitis: Insights from a Multicenter Retrospective Study.J Inflamm Res. 2024 Dec 24;17:11529-11543. doi: 10.2147/JIR.S481729. eCollection 2024. J Inflamm Res. 2024. PMID: 39735892 Free PMC article.
-
Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports.Clin Exp Immunol. 2024 Jan 9;215(1):27-36. doi: 10.1093/cei/uxad109. Clin Exp Immunol. 2024. PMID: 37724585 Free PMC article.
-
The association between autoimmune encephalitis mediated by N-methyl-ᴅ-aspartate receptor autoantibodies and COVID-19: a systematic review.Encephalitis. 2024 Jan;4(1):3-10. doi: 10.47936/encephalitis.2023.00171. Epub 2023 Dec 21. Encephalitis. 2024. PMID: 38126079 Free PMC article.
-
Anti-N-methyl-D-aspartate receptor encephalitis in adults: a systematic review and analysis.Neuropsychiatr. 2024 Jun;38(2):92-101. doi: 10.1007/s40211-023-00478-9. Epub 2023 Aug 7. Neuropsychiatr. 2024. PMID: 37548868 English.
-
Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor.Front Immunol. 2023 Jul 10;14:1195172. doi: 10.3389/fimmu.2023.1195172. eCollection 2023. Front Immunol. 2023. PMID: 37503335 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical